Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN002018 | 184.0741 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 184.0742 | 5.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 214.2538 | 0.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 226.1823 | 0.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 244.192 | 0.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 284.3318 | 1.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 286.23 | 2.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | Sphingosine(d17:1) iSTD | 286.275 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | AC(10:1) | 314.232 | 0.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | AC(10:0) | 316.2503 | 0.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | CUDA iSTD | 341.2806 | 0.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | AC(12:1) | 342.2622 | 0.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | MG(17:0/0:0/0:0) iSTD | 367.281 | 3.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | AC(14:2) | 368.2792 | 0.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 369.225 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | Cholesterol | 369.3522 | 4.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 369.3526 | 10.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 369.3527 | 10.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 369.3533 | 10.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | Cholesterol d7 iSTD | 376.3957 | 4.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | AC(16:0) | 400.3439 | 1.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 416.3647 | 4.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | DG(18:1/2:0/0:0) iSTD | 421.293 | 3.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | AC(18:2) | 424.3436 | 1.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | AC(18:1) | 426.3577 | 1.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 429.3721 | 5.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 430.3812 | 5.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | LPE(17:1) iSTD | 466.293 | 1.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC(14:0) | 468.3094 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 474.4176 | 4.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | LPE(18:2) | 478.2947 | 1.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC (p-16:0) or LPC (o-16:1) | 480.3401 | 1.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPE(18:0) | 482.3252 | 2.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC(15:0) | 482.3261 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC (o-16:0) | 482.3659 | 1.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 488.4333 | 5.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | LPC(16:1) | 494.3238 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | DG(12:0/12:0/0:0) iSTD | 495.3461 | 4.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC(16:0) | 496.3401 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 496.3403 | 1.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | LPE(20:4) | 502.2961 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC (p-18:0) or LPC (o-18:1) | 508.3762 | 1.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC(17:0) iSTD | 510.3556 | 1.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC(18:3) | 518.3251 | 0.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 520.3394 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | LPC(18:2) | 520.3397 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 522.3547 | 1.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | LPC(18:1) | 522.3552 | 1.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC(18:0) | 524.3709 | 2.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 524.3713 | 2.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | Cer(d18:1/17:0) iSTD | 534.5242 | 6.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 536.4365 | 8.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 536.4372 | 7.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 536.4375 | 8.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | Cer(d34:1) | 538.5183 | 5.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC(20:5) | 542.3251 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC(20:4) | 544.3394 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC(20:3) | 546.3559 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC (20:2) | 548.3715 | 1.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 549.4875 | 10.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | LPC (20:1) | 550.3866 | 2.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 551.5022 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 551.5048 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | LPC (20:0) | 552.4034 | 3.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 565.5579 | 11.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | Cer(d36:1) | 566.5504 | 6.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | LPC (22:6) | 568.3398 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 568.4285 | 3.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | LPC(22:5) | 570.3561 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 575.5032 | 10.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 577.518 | 10.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 577.5183 | 4.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 577.5186 | 5.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 577.5204 | 10.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | DG(32:1) | 584.5203 | 6.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | Cer(d38:1) | 594.5817 | 7.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 601.5185 | 10.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 603.5338 | 5.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 603.5342 | 4.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 603.5342 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 603.536 | 10.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 605.5492 | 5.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 605.55 | 5.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | DG(34:2) | 610.5454 | 6.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | DG(34:0) | 619.5252 | 7.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | Cer(d40:1) | 622.612 | 7.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 627.5339 | 5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 629.5384 | 4.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 629.5486 | 5.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | Cer(d42:2) B | 630.6168 | 7.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 631.5654 | 5.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 631.5656 | 5.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | DG(34:1) | 633.4887 | 7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | DG(36:4) A | 634.5394 | 5.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(12:0/13:0) iSTD | 636.4604 | 3.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | Cer(d41:1) | 636.6285 | 8.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | DG(36:2) | 638.579 | 7.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | DG(36:3) | 641.5128 | 6.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | DG(36:1) | 645.5408 | 7.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | CE(16:1) | 645.5568 | 10.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 647.4583 | 7.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d30:1) | 647.5103 | 3.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | Cer(d42:2) A | 648.6258 | 7.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 649.4684 | 7.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC (16:0/9:0(CHO)) | 650.4379 | 2.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | Cer(d42:1) | 650.6438 | 8.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | DG(36:6) | 651.4289 | 5.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 651.5339 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 663.4537 | 5.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | CE(18:3) | 669.5598 | 10.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | SM(d32:2) | 673.5268 | 3.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 673.5421 | 5.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 673.5789 | 10.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | CE(18:1) | 673.5898 | 10.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 674.5114 | 5.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d32:1) | 675.5423 | 4.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(28:0) | 678.5065 | 4.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 687.548 | 10.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d33:1) | 689.5582 | 4.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 690.5286 | 5.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 690.5429 | 4.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC 30:0e; | 692.5603 | 5.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | CE(20:5) | 693.5574 | 9.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 694.684 | 8.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | CE(20:4) | 695.5732 | 10.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | CE(20:3) | 697.5928 | 10.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 700.5276 | 5.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 700.5283 | 5.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 700.5714 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d34:2) | 701.5582 | 4.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PE(p-34:1)/PE(o-34:2) | 702.5424 | 6.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | SM(d34:1) | 703.575 | 4.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 703.5751 | 4.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC 30:1; | 704.5229 | 4.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 704.5524 | 6.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 704.555 | 6.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d34:0) | 705.589 | 5.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(30:0) | 706.542 | 4.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 706.582 | 4.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PE(34:2) | 716.5275 | 5.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 716.5302 | 5.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 716.5468 | 5.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-32:1)/PC(o-32:2) | 716.5589 | 4.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 717.5594 | 5.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 717.5662 | 5.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d18:1/17:0) iSTD | 717.5894 | 5.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(31:1) | 718.538 | 4.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 718.5477 | 5.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC (p-32:0) or PC (o-32:1) | 718.5704 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 718.5732 | 5.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 719.5551 | 5.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 719.5677 | 4.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | CE(22:6) | 719.573 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 719.5742 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 719.5795 | 5.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PE(17:0/17:0) iSTD | 720.5533 | 6.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 720.5562 | 5.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(31:0) | 720.5562 | 5.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(o-32:0) | 720.5897 | 5.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 721.5458 | 5.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 721.5691 | 5.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 721.578 | 6.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 721.593 | 5.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 722.5401 | 5.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PE(p-36:4)/PE(o-36:5) | 724.5268 | 5.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 724.5484 | 3.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 726.5424 | 5.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 726.5433 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 726.5498 | 5.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 726.5603 | 4.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 727.5604 | 4.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d36:3) | 727.5731 | 4.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PE(p-36:2)/PE(o-36:3) | 728.558 | 6.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 728.5587 | 6.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 728.559 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 729.5414 | 4.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 729.5682 | 6.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d36:2) | 729.5875 | 4.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(32:2) | 730.5379 | 4.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 730.558 | 5.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 730.5666 | 5.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PE(p-36:1)/PE(o-36:2) | 730.5749 | 6.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | SM(d36:1) | 731.6049 | 5.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(32:1) | 732.5535 | 4.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 732.5803 | 6.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC 33:1e; | 732.5886 | 5.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | SM(d36:0) | 733.6195 | 5.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 734.5547 | 5.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 734.5593 | 4.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 734.5612 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(32:0) | 734.5693 | 5.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 735.5607 | 4.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PE(36:4) | 740.5233 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 740.5549 | 5.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(42:0) | 740.676 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 741.531 | 5.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(42:2) | 741.6006 | 8.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 742.5524 | 5.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 742.5552 | 5.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 742.5594 | 5.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 742.5682 | 5.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-34:2)/PC(o-34:3) | 742.5718 | 5.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 743.5584 | 5.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 743.5664 | 5.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(42:1) | 743.6141 | 9.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 744.5515 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(33:2) | 744.5536 | 4.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 744.5572 | 5.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PE(36:2) | 744.5665 | 5.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 744.572 | 6.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 744.5786 | 5.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 744.5885 | 5.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-34:1)/PC(o-34:2) | 744.5889 | 5.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 745.555 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 745.5555 | 4.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 745.5565 | 4.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 745.5751 | 5.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 745.5986 | 5.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM (d37:1) | 745.6182 | 5.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(33:1) | 746.5688 | 5.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PE(36:1) | 746.5699 | 6.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC 34:1e; | 746.6048 | 5.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 748.535 | 5.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(33:0) | 748.5833 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(o-34:0) | 748.6205 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 749.5363 | 5.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 749.5864 | 5.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PE(p-38:5)/PE(o-38:6) | 750.5433 | 5.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 750.5477 | 5.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 750.5792 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 751.5477 | 5.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 752.5574 | 5.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PE(p-38:4)/PE(o-38:5) | 752.5591 | 6.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(34:4) | 754.5377 | 4.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 754.5437 | 5.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 754.5614 | 6.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 754.5736 | 6.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(34:3) A | 756.553 | 4.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(34:3) C | 756.553 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(34:3) B | 756.5531 | 4.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 756.554 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 756.5541 | 5.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 757.5561 | 4.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 757.5561 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 757.5588 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d38:2) | 757.6196 | 5.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(34:2) | 758.5705 | 5.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 758.6024 | 5.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 758.7947 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d38:1) | 759.6344 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 760.5817 | 5.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(34:1) | 760.5865 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 760.5952 | 6.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 760.6126 | 6.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 760.8112 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 760.8115 | 5.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 760.8134 | 5.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 761.5772 | 5.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM (d38:0) | 761.6454 | 6.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 761.8195 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 761.8248 | 5.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 762.5275 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(34:0) | 762.6015 | 6.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 762.824 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PE(38:6) | 764.5232 | 5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(p-36:5)/PC(o-36:6) | 764.5576 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 764.5881 | 5.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 764.6126 | 5.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 766.5421 | 5.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 766.5446 | 5.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 766.5519 | 5.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 766.5598 | 5.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-36:4)/PC(o-36:5) | 766.5709 | 5.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 766.5734 | 4.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 767.5443 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 767.552 | 5.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 767.566 | 5.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(35:4) | 768.5536 | 4.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PE(38:4) | 768.5538 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 768.5543 | 5.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 768.5648 | 5.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 768.5669 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 768.5679 | 5.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 768.5771 | 5.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 768.5881 | 5.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC (p-36:3) or PC (o-36:4) | 768.5889 | 5.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 769.558 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 770.5217 | 4.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(35:3) | 770.5693 | 4.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 770.5872 | 6.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 770.6035 | 5.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 770.6042 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC 36:3e; | 770.6046 | 5.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(p-36:2)/PC(o-36:3) | 770.6049 | 6.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 771.5975 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 771.6064 | 5.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 771.6135 | 6.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM (d39:2) | 771.6311 | 5.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(44:1) | 771.6469 | 9.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 772.5764 | 5.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(35:2) B | 772.5846 | 5.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(35:2) A | 772.5847 | 5.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 772.5907 | 6.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-36:1)/PC(o-36:2) B | 772.6173 | 6.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 772.6193 | 6.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-36:1)/PC(o-36:2) A | 772.6201 | 6.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 772.6212 | 6.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 773.581 | 5.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 773.5884 | 5.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 773.6017 | 6.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 773.616 | 6.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 773.6227 | 6.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d39:1) | 773.6516 | 6.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(44:0) | 773.6612 | 10.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 774.5641 | 5.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 774.5992 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(35:1) | 774.5993 | 5.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 774.6202 | 6.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC 36:1e; | 774.636 | 6.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 775.5984 | 5.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 776.5524 | 5.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 776.5576 | 5.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 776.5665 | 5.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 776.5782 | 4.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 776.6114 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(36:6) | 778.5396 | 4.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PE(p-40:5)/PE(o-40:6) | 778.5757 | 6.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 780.5513 | 5.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 780.5519 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(36:5)A | 780.5532 | 4.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(36:5) D | 780.5532 | 4.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(36:5) C | 780.5536 | 4.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 780.5614 | 5.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PE(p-40:4)/PE(o-40:5)A | 780.5872 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 781.0426 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 782.5679 | 5.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(36:4) A | 782.5688 | 4.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(36:4) B | 782.5688 | 4.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(36:4) C | 782.5703 | 5.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 783.0719 | 5.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 783.5698 | 4.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 783.5733 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 784.579 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 784.5828 | 6.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(36:3) A | 784.5851 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(36:3) B | 784.5853 | 5.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | GlcCer(d40:1) | 784.6645 | 7.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 785.5874 | 5.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(44:2) | 785.6058 | 9.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | SM(d40:2) B | 785.6512 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | SM(d40:2) A | 785.6522 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(36:2) | 786.6017 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 786.6018 | 5.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 786.6021 | 5.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 786.6121 | 6.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 786.649 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d40:1) | 787.6679 | 6.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 788.6162 | 6.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(36:1) | 788.6168 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(46:4) A | 788.6748 | 8.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 788.8453 | 5.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 788.8464 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d40:0) | 789.6807 | 7.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 790.5425 | 6.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 790.5503 | 5.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 790.5583 | 5.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 790.5715 | 6.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-38:6)/PC(o-38:7) | 790.5735 | 5.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 790.5917 | 6.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 790.5944 | 5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 790.596 | 5.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC 36:0; | 790.6329 | 6.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 791.5773 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 791.6002 | 5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 791.6273 | 6.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(37:6) | 792.5548 | 4.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 792.5554 | 5.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 792.5671 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 792.5695 | 5.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 792.5779 | 5.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 792.5859 | 4.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-38:5)/PC(o-38:6) A | 792.5881 | 5.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(p-38:5)/PC(o-38:6) B | 792.5889 | 5.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 792.5948 | 5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 792.6143 | 5.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 793.5885 | 5.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 794.57 | 5.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(37:5) | 794.5715 | 4.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 794.5958 | 6.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 794.6019 | 5.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 794.6038 | 5.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-38:4)/PC(o-38:5) A | 794.6041 | 5.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 795.5379 | 5.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(46:3) B | 795.6497 | 9.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 796.5356 | 5.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(37:4) | 796.5832 | 5.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 796.5842 | 5.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 796.5933 | 5.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 796.5995 | 5.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 796.6156 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-38:3)/PC(o-38:4) A | 796.6181 | 5.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(p-38:3)/PC(o-38:4) B | 796.6183 | 6.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(46:0) | 796.7381 | 10.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 796.7383 | 10.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 797.7354 | 10.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 798.5585 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 798.5678 | 5.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC (37:3) | 798.6008 | 5.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC (p-38:2) or PC (o-38:3) | 798.6368 | 6.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 799.5718 | 5.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d41:2) A | 799.6669 | 6.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | SM(d41:2)B | 799.6677 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 800.6151 | 5.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(37:2) | 800.6157 | 6.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 800.652 | 6.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 801.6788 | 7.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d41:1) | 801.6833 | 7.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 802.6676 | 7.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 804.5512 | 5.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(38:7) | 804.5543 | 4.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 805.6076 | 4.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 806.568 | 4.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 806.5687 | 4.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(38:6) B | 806.5701 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 807.5693 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 807.5758 | 4.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 808.5693 | 4.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 808.5696 | 4.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 808.5825 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 808.5826 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 808.5831 | 5.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 808.5841 | 5.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(38:5) A | 808.585 | 5.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 808.7371 | 10.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 809.0842 | 5.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 809.5843 | 4.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 809.6379 | 5.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 810.5849 | 4.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 810.5985 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(38:4) A | 810.5996 | 5.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(38:4) B | 810.5999 | 5.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(38:4) C | 810.6022 | 5.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | GlcCer(d42:2) | 810.6809 | 7.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 811.5925 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 811.6077 | 6.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 811.6152 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(46:3) A | 811.6187 | 9.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | SM(d42:3) | 811.6663 | 6.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 812.6132 | 5.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 812.6157 | 5.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 812.6162 | 6.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 812.631 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 812.6506 | 6.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | GlcCer(d42:1) | 812.6954 | 7.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 813.6174 | 5.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(46:2) | 813.6373 | 9.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 813.6832 | 6.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d42:2) | 813.6837 | 6.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 814.6316 | 6.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 814.6325 | 6.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(38:2) | 814.6325 | 6.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 814.6865 | 6.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(48:5) | 814.6867 | 8.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(46:1) | 815.6517 | 10.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 815.6896 | 6.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d42:1) | 815.6992 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 816.6205 | 5.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(38:1) | 816.6507 | 6.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 817.6116 | 5.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 817.6246 | 5.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 817.6589 | 6.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 817.7027 | 7.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM (d42:0) | 817.7134 | 7.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(p-40:6)/PC(o-40:7) A | 818.604 | 5.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 818.6144 | 5.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 818.6212 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 818.6366 | 5.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 818.6371 | 5.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 820.5302 | 5.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC (39:6) | 820.5824 | 5.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 820.6198 | 5.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-40:5)/PC(o-40:6) | 820.6205 | 5.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 820.7371 | 10.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 821.7454 | 10.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-40:4)/PC(o-40:5) | 822.6352 | 6.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 822.7446 | 10.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 824.5581 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 824.5621 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 824.5633 | 5.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(39:4) | 824.6158 | 5.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(p-40:3)/PC(o-40:4) | 824.6519 | 6.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(48:0) | 824.772 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 824.7961 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 825.5602 | 5.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(48:2) | 825.6936 | 10.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 826.5758 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 826.7799 | 10.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM(d43:2) | 827.6981 | 7.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(48:1) | 827.7094 | 10.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | SM(d43:1) | 829.7128 | 7.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 830.5667 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(40:8) | 830.5683 | 4.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(40:7) B | 832.5847 | 4.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 832.5847 | 5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(40:7) A | 832.5848 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(49:3) | 832.7355 | 9.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 833.5865 | 4.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 834.5872 | 4.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(40:6)B | 834.6 | 5.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 834.6006 | 5.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 834.6007 | 5.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(40:6) A | 834.6027 | 5.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 835.5955 | 5.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 835.6133 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 836.6028 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 836.6147 | 5.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(40:5) A | 836.6161 | 5.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(40:5) B | 836.6161 | 5.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 837.6187 | 5.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 837.6224 | 5.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(48:4) A | 837.6361 | 9.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 838.5098 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 838.5216 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 838.6309 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(40:4) | 838.6311 | 6.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 839.5128 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 839.5206 | 5.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 839.6428 | 6.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(48:3) | 839.6534 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 840.5115 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 840.5256 | 5.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 840.6212 | 5.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 840.6483 | 6.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 841.6185 | 5.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | SM (d44:2) | 841.7113 | 7.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 842.5253 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 842.6353 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 842.6378 | 5.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 842.663 | 6.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 844.6519 | 5.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 844.7363 | 9.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 845.6572 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 846.6541 | 5.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 846.6561 | 5.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 846.6685 | 6.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC 40:0; | 846.6932 | 8.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(50:5) | 847.6789 | 9.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 847.749 | 10.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 847.7657 | 10.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 848.5383 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 848.5434 | 5.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-42:5)/PC(o-42:6) B | 848.6504 | 6.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC(p-42:5)/PC(o-42:6) A | 848.6517 | 6.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 850.5543 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-42:4)/PC(o-42:5) | 850.6678 | 6.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 850.8176 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(50:3) A | 851.7092 | 10.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 851.8026 | 10.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC (p-42:3) or PC (o-42:4) | 852.683 | 7.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(50:2) | 853.7262 | 10.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 853.7947 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 853.8073 | 11.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(42:10) | 854.5724 | 4.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 854.735 | 10.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(49:2) | 855.6843 | 10.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 855.728 | 10.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(49:1) | 857.7047 | 10.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 857.7503 | 10.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 858.5994 | 4.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 859.5363 | 4.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 862.5092 | 5.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | GlcCer(d34:1) | 862.6236 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC (42:6) | 862.6357 | 5.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 863.7809 | 10.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 864.5255 | 5.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 864.6269 | 4.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC (42:5) | 864.6444 | 6.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 864.7988 | 10.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(51:1) | 864.8005 | 11.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 865.5282 | 5.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 865.5354 | 5.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(50:4) | 865.6684 | 9.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 866.5406 | 5.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 866.5421 | 5.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 867.5408 | 5.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 867.5436 | 5.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 868.5405 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 868.5594 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 868.6526 | 5.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG d5(17:0/17:1/17:0) iSTD | 869.8309 | 11.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC 42:2; | 870.6937 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(52:5) | 870.7531 | 9.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 870.7535 | 9.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(50:1) | 871.7167 | 10.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 872.5383 | 5.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 872.7686 | 10.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(52:6) | 873.6952 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | PC 42:0; | 874.7247 | 8.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 874.7795 | 10.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 875.6815 | 5.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 875.682 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 875.7103 | 9.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 875.7808 | 10.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 876.5691 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 876.5696 | 5.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 876.5707 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 876.6827 | 6.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 876.7882 | 10.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 876.7974 | 11.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 877.6976 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(52:4) | 877.7256 | 10.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 878.5869 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC(p-44:4)/PC(o-44:5) | 878.6984 | 7.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 878.7417 | 10.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(51:4) | 879.687 | 9.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 879.7329 | 10.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 879.8107 | 10.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 879.8251 | 10.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 879.8306 | 11.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 880.8134 | 11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(51:3) | 881.6977 | 10.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 882.7549 | 10.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 882.7648 | 10.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(51:2) | 883.717 | 10.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 883.7666 | 10.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 885.6739 | 9.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 887.5638 | 5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 888.7969 | 10.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG (53:5) | 889.7271 | 10.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 890.789 | 11.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 890.8116 | 10.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 890.8135 | 10.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 891.684 | 9.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(53:4) | 891.7421 | 10.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 892.8264 | 10.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(53:1) | 892.8312 | 11.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 892.8337 | 10.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 893.5558 | 5.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 893.5594 | 5.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 893.5651 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(53:3) | 893.7581 | 10.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 893.8331 | 10.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 893.84 | 10.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(52:3) | 895.7152 | 10.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 896.5388 | 4.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(54:6) A | 896.7692 | 9.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(54:8) | 897.6954 | 9.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 897.7181 | 10.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 897.7197 | 10.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(52:2) | 897.7323 | 10.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 897.7693 | 9.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | PC 44:2; | 898.7256 | 8.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 898.7745 | 9.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(54:7) A | 899.7122 | 9.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(54:7) B | 899.7131 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(52:1) | 899.7469 | 11.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 900.5666 | 5.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 901.7911 | 10.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 902.7315 | 9.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 902.8029 | 10.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 902.835 | 11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 903.6575 | 6.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 903.7129 | 5.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 903.7131 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 903.7135 | 5.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 904.8219 | 10.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 904.8276 | 10.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 904.8301 | 10.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(54:4) | 905.7593 | 10.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 905.8267 | 10.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 906.8455 | 10.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 906.8465 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 906.8484 | 11.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 907.7601 | 10.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 907.7842 | 10.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 907.7941 | 10.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 909.7839 | 11.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 909.7984 | 10.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(53:2) | 911.7452 | 11.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 913.7925 | 10.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 913.7956 | 10.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 914.8151 | 10.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 915.8121 | 10.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 915.8137 | 10.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 916.8301 | 10.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 916.8313 | 10.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(55:3) | 916.833 | 11.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 917.699 | 9.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(54:6) C | 917.7009 | 10.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 917.8292 | 10.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(56:9) | 918.7579 | 9.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 918.8459 | 10.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(55:2) | 918.8483 | 11.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 918.8493 | 10.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(54:5) B | 919.7133 | 10.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 919.7148 | 10.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(54:5) A | 919.7154 | 10.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 920.7177 | 10.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 920.8539 | 10.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 920.8607 | 11.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 920.8641 | 10.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(55:1) | 920.8653 | 11.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 920.8916 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 921.8882 | 10.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 922.7301 | 10.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 922.7354 | 10.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 922.8701 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(54:3) | 923.7479 | 10.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 924.7499 | 11.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(54:2) | 925.7622 | 11.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 925.796 | 10.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 925.8034 | 10.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 926.8013 | 10.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(56:7) A | 927.7416 | 10.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(56:7) B | 927.7421 | 10.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(54:1) | 927.7773 | 11.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 927.814 | 10.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 927.8253 | 10.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 928.8121 | 10.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 928.8295 | 10.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 929.8329 | 11.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 930.8367 | 10.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 930.8465 | 10.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 930.8475 | 10.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(56:5) C | 931.7751 | 10.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 931.8434 | 10.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 931.8473 | 11.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 932.8496 | 10.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 932.8623 | 10.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 932.863 | 11.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 932.8643 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 932.9058 | 10.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 933.8616 | 11.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 933.8639 | 10.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 934.8691 | 10.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(56:1) | 934.8788 | 11.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 934.8799 | 10.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 934.8959 | 10.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 935.8879 | 10.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(56:2) | 937.8287 | 11.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 938.8093 | 9.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 940.8226 | 10.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 940.8298 | 10.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 940.8299 | 9.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(56:8) B | 941.6983 | 9.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(56:8) A | 941.7003 | 9.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 941.8252 | 10.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 942.8467 | 10.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 942.8475 | 10.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 943.8492 | 10.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(58:10) | 944.7695 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 944.8621 | 10.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 944.8641 | 10.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(56:6) | 945.7318 | 10.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 945.8649 | 10.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(58:9) | 946.7841 | 9.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 946.8764 | 11.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 946.8815 | 10.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(57:2) | 946.8821 | 11.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(56:5) A | 947.7379 | 10.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(56:5) B | 947.7451 | 10.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 947.8824 | 11.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(58:8) | 948.8005 | 10.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 948.8883 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 948.8937 | 11.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(57:1) | 948.8982 | 11.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(56:4) | 949.7536 | 11.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(56:3) | 951.7745 | 11.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 951.8145 | 10.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 954.8456 | 10.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 954.847 | 9.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 954.8471 | 9.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(58:5) | 954.8492 | 11.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 956.863 | 10.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 956.8633 | 10.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(58:4) | 956.8654 | 11.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(58:6) | 957.7975 | 10.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 958.8716 | 10.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 958.8792 | 10.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 958.8793 | 10.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 959.8796 | 11.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 959.8831 | 11.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 960.8963 | 10.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 961.8996 | 11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 962.9047 | 10.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 962.9061 | 10.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 962.9102 | 11.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(58:1) | 962.9108 | 12.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 963.9194 | 11.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(58:0) | 964.9255 | 12.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(58:2) | 965.8561 | 11.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 966.8472 | 9.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 967.851 | 9.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 968.8613 | 10.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 968.8629 | 10.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 969.8661 | 10.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 970.8647 | 10.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 970.88 | 10.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | Lactosylceramide (d18:1/24:1(15Z)) | 972.7347 | 6.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 972.8809 | 10.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(59:3) | 972.8958 | 11.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 972.8962 | 10.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 973.898 | 11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 973.9026 | 10.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 974.9037 | 10.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 974.9115 | 11.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(59:2) | 974.9127 | 11.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(58:3) | 979.811 | 11.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 980.8632 | 9.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 982.8785 | 10.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 983.8716 | 10.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 984.8958 | 10.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(60:4) | 984.8959 | 11.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(60:3) | 986.9096 | 11.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 986.9111 | 10.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 986.9124 | 10.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 987.9155 | 10.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 987.9192 | 10.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 988.9211 | 11.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(60:2) | 988.9258 | 12.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 988.9265 | 11.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | TG(60:1) | 990.942 | 12.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(62:4) | 1012.9243 | 11.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(62:3) | 1014.9421 | 12.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(62:2) | 1016.9568 | 12.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | CE(18:2) | 1017.9407 | 10.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(62:1) | 1018.9736 | 12.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(64:4) | 1040.9563 | 12.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(64:3) | 1042.9734 | 12.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | TG(64:2) | 1044.9877 | 12.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | CE(22:1) iSTD | 1076.0135 | 11.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN002018 | 1159.334 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 1162.3571 | 5.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 1162.8571 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 1194.8171 | 5.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 1195.8302 | 5.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN002018 | 1196.8181 | 5.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
